Related Experiment Video
Updated: Jul 6, 2026
09:32
Manufacturing Abdominal Aorta Hydrogel Tissue-Mimicking Phantoms for Ultrasound Elastography Validation
Published on: September 19, 2018
LDL size and subclasses in patients with abdominal aortic aneurysm
International Journal of Cardiology
|March 28, 2008
Summary
Patients with abdominal aortic aneurysm (AAA) exhibit distinct dyslipidemia, characterized by lower HDL-cholesterol and smaller LDL particle size. Increased small, dense LDL is common in AAA patients and independently associated with the condition.
Area of Science:
- Cardiovascular Medicine
- Lipid Metabolism
- Vascular Biology
Background:
- The specific lipid profile and low-density lipoprotein (LDL) characteristics in patients with abdominal aortic aneurysm (AAA) remain incompletely understood.
- Dyslipidemia is a known risk factor for cardiovascular diseases, but its precise role in AAA pathogenesis requires further elucidation.
Purpose of the Study:
- To investigate and define the type of dyslipidemia in patients newly diagnosed with abdominal aortic aneurysm (AAA).
- To compare plasma lipid levels, LDL size, and LDL subclasses between AAA patients and healthy controls.
Main Methods:
- Cross-sectional study involving 30 male patients with newly diagnosed AAA and 26 age- and BMI-matched male healthy controls.
- Measurement of plasma lipids, including HDL-cholesterol and triglycerides.
- Analysis of LDL size and subclasses using gradient gel electrophoresis.
Main Results:
- AAA patients exhibited significantly lower HDL-cholesterol (p<.0001) and higher triglycerides (p=.0002) compared to controls.
- Patients with AAA presented with smaller LDL particle size (p<.0001) and increased levels of small, dense LDL (p=.0210).
- Multivariate analysis confirmed that small LDL size was independently associated with the presence of AAA (p=.0350).
Conclusions:
- Patients with abdominal aortic aneurysm (AAA) display a characteristic dyslipidemia profile, including reduced HDL-cholesterol and elevated triglycerides.
- The presence of smaller LDL particle size and increased small, dense LDL is a common feature in AAA patients.
- Small, dense LDL may represent a significant, independently associated factor in the pathophysiology of abdominal aortic aneurysms.
Related Concept Videos
01:26Aneurysm III: Interprofessional Care
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
01:30Aneurysm I: Introduction
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:22Aneurysm IV: Nursing Management
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...